
Clinical
Canopy Presents Research at 2022 ASCO Annual Meeting
Canopy’s two studies demonstrate 22% - 45% higher treatment persistence at 3 months and 22% lower rates of adverse clinical events
Read more
Canopy’s two studies demonstrate 22% - 45% higher treatment persistence at 3 months and 22% lower rates of adverse clinical events
Read more
Canopy works with leading oncology practices nationwide to drive the best possible outcomes for over 50,000 cancer patients
Read more
Jan 01 2023

Nov 07 2022

Sep 06 2022

Mar 19 2022

Mar 18 2022

Mar 17 2022

Mar 17 2022